title: Circulating Long Noncoding RNAs in Personalized Medicine: Response to Pioglitazone Therapy in Type 2 Diabetes.
authors.forename: David
authors.initials: D
authors.lastname: de Gonzalo-Calvo
authors.forename: Franziska
authors.initials: F
authors.lastname: Kenneweg
authors.forename: Claudia
authors.initials: C
authors.lastname: Bang
authors.forename: Rocío
authors.initials: R
authors.lastname: Toro
authors.forename: Rutger W
authors.initials: RW
authors.lastname: van der Meer
authors.forename: Luuk J
authors.initials: LJ
authors.lastname: Rijzewijk
authors.forename: Johannes W A
authors.initials: JW
authors.lastname: Smit
authors.forename: Hildo J
authors.initials: HJ
authors.lastname: Lamb
authors.forename: Vicenta
authors.initials: V
authors.lastname: Llorente-Cortes
authors.forename: Thomas
authors.initials: T
authors.lastname: Thum
mesh_terms: D015415:Biomarkers / Q000097:blood; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D000077205:Pioglitazone; D057285:Precision Medicine / Q000379:methods*; D062085:RNA, Long Noncoding / Q000097:blood*; D045162:Thiazolidinediones / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D007004:Hypoglycemic Agents; D062085:RNA, Long Noncoding; D045162:Thiazolidinediones; D000077205:Pioglitazone